
0:00
14:39
Severe refractory asthma, which affects approximately 1% to 5% of patients with asthma, is associated with increased morbidity and mortality. Author Juan Carlos Cardet, MD, MPH, of the University of South Florida joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the management of patients with severe refractory asthma, including first-line medications and biologics.
Related Content:
-----------------------------------
Mais episódios de "JAMA Clinical Reviews"



Não percas um episódio de “JAMA Clinical Reviews” e subscrevê-lo na aplicação GetPodcast.







